CanBas News

CanBas: Company presentation materials 2024/5 3rd quarter financial results reflection version

May 10 14:30

CanBas: Quarterly Report - 25th Quarter 3rd Quarter (2024/01/01 to 2024/03/31)

May 10 14:16

CanBas: Confirmation letter

May 10 14:16

CanBas: Notice regarding the recording of non-operating profit and loss

May 10 14:10

CanBas: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/6 [Japanese GAAP] (unconsolidated)

May 10 14:10

CanBas: Notice Concerning the Monthly Exercise Status of Stock Acquisition Rights with Exercise Price Amendment Clauses through Third-Party Allotment

May 1 14:00

Canvas: Change Report (Stock Certificates Subject to Special Cases, etc.)

Apr 19 14:23

CanBas: Notice Concerning the Monthly Exercise Status of Stock Acquisition Rights with Exercise Price Amendment Clauses through Third-Party Allotment

Apr 1 16:30

Canvas: Change Report (Stock Certificates Subject to Special Cases, etc.)

Mar 6 14:18

Canvas: Company Presentation Materials March 2024 Edition

Mar 1 14:15

Canvas: Notice regarding the monthly exercise status of stock acquisition rights with price correction clauses exercised through third-party allotment

Mar 1 14:10

Canvas: Notice of publication in a journal on CBP501 clinical phase 2 trial results (progress of disclosure information)

Feb 29 15:02

Canvas: Explanatory materials on business plans and growth potential (2024/2 updated version)

Feb 28 14:00

Canvas: Announcement of the start of discussions with the EMA for the start of the CBP501 European Clinical Phase 3 trial

Feb 27 14:00

Canvas: Notice of publication in a journal on CBP501 clinical phase 2 trial results

Feb 26 11:00

Canvas: Change Report (Stock Certificates Subject to Special Cases, etc.)

Feb 21 14:25

CanBas: Documents on the “2nd Quarter Financial Results Briefing for the Fiscal Year Ending 2024/6” held on 2024/2/15

Feb 15 10:30

CanBas: Supplementary Q&A announcement on “CBP501 Next Phase Clinical Trial Schedule in the US and Clinical Phase 3 Clinical Trial Preparation in Europe” published on 2/9

Feb 14 14:00

canvas: confirmation

Feb 9 15:13

Canvas: Quarterly Report - 25th Quarter 2nd Quarter (2023/10/01 to 2023/12/31)

Feb 9 15:12